New Medical Centre Alexandria results, Q2 2025
Net profit, assets, equity and cash flow for Q2 2025, against the same period a year earlier, from the published financial statements.
Net profit13.65 millionEGP · −54.2% vs the same period a year earlier
Shareholders' equity243 millionEGP · +10.0% vs the same period a year earlier
Operating cash flow-295 thousandEGP · −101.1% vs the same period a year earlier
In short
- New Medical Centre Alexandria's net profit for Q2 2025 was about 13.65 million EGP, down −54.2% from 29.82 million EGP in Q2 2024.
- Operating cash flow for Q2 2025 was negative at 295 thousand EGP.
Key lines against the same period a year earlier
This periodQ2 2024Change
Net profit13.65 million29.82 million−54.2%
Gross profit39.57 million120 million−66.9%
Total assets—366 million—
Total liabilities—145 million—
Shareholders' equity243 million221 million+10.0%
Total liabilities and equity396 million366 million+8.0%
Operating cash flow-295 thousand26.51 million−101.1%
Investing cash flow-2.38 million-40.51 million+94.1%
Financing cash flow—6.14 million—
Net change in cash—-7.86 million—
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
New Medical Centre Alexandria's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy